Variant report
Variant | esv3463574 |
---|---|
Chromosome Location | chr3:157419571-157422250 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370955018 | chr3:157419576-157419577 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs62278759 | chr3:157419603-157419604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375545762 | chr3:157419637-157419638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535026234 | chr3:157419643-157419644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184206711 | chr3:157419664-157419665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150893202 | chr3:157419670-157419671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9289990 | chr3:157419690-157419691 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs78311654 | chr3:157419744-157419745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79708302 | chr3:157419745-157419746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556655859 | chr3:157419760-157419761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4680393 | chr3:157419774-157419775 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs539136400 | chr3:157419775-157419776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139417593 | chr3:157419787-157419788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372503210 | chr3:157419790-157419791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs16828145 | chr3:157419849-157419850 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs540578686 | chr3:157419886-157419887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561916688 | chr3:157419890-157419891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188484434 | chr3:157419895-157419896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181262100 | chr3:157419957-157419958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7609979 | chr3:157419976-157419977 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs531070325 | chr3:157420026-157420027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553258897 | chr3:157420069-157420070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35416171 | chr3:157420076-157420077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552381746 | chr3:157420089-157420090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564750928 | chr3:157420091-157420092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7620316 | chr3:157420121-157420122 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs545386853 | chr3:157420156-157420157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545675316 | chr3:157422006-157422007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115485258 | chr3:157422033-157422034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527240458 | chr3:157422036-157422037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531459206 | chr3:157422058-157422059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549111210 | chr3:157422066-157422067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187030211 | chr3:157422136-157422137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21509527 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:157418400-157419600 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr3:157418400-157420200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:157422000-157423400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |